ANGLE ORD 10P news, videos and press releases - Page 2
For more news please use our advanced search feature.
ANGLE ORD 10P - More news...
ANGLE ORD 10P - More news...
- Angle PLC Announces Pharma Services Contract with Artios Pharma
- Angle PLC Announces Board Change - Appointment of New Chairman
- Angle PLC Announces Results for the Year Ended 31 December 2022
- ANGLE Parsortix Poster Presented at AACR 2023
- Angle PLC Announces Notice of Preliminary Results and Webcast
- Angle PLC Announces Issue of LTIP Options and Share Options
- Angle PLC Announces Holding(s) in Company
- Angle PLC Announces Director/PDMR Shareholding
- Angle PLC Announces Appointment of Non-Executive Director
- Angle PLC Announces Holding(s) in Company
- Angle PLC Announces Two Parsortix Posters Presented at SABCS
- Angle PLC Announces Issue of Equity
- Angle PLC Announces Multiple Downstream Analysis Techniques for CTCs
- Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
- Angle PLC Announces Preliminary Results
- Angle PLC Announces Notice of Preliminary Results and Webcast
- Angle PLC Announces Poster on Parsortix System Presented at AACR 2022
- Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
- Angle PLC Announces Rapid Information on Patient Response to Therapies
- Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients
- Angle PLC Announces Update on Laboratory Accreditation
- Angle PLC Announces Holding(s) in Company
- Angle PLC Announces Issue of Equity
- Angle PLC Announces Potential in Immunotherapy Treatment Selection
- Angle PLC Announces Concordance of Parsortix with tissue biopsy
- Angle PLC Announces Update on Lab Accreditation and Ovarian Study
- Angle PLC Announces Insight into Drug Resistance in NSCLC
- Angle PLC Announces Issue of Equity
- Angle PLC Announces Issue of Equity
- Angle PLC Announces Parsortix in RNA analysis of CTCs as tool in NSCLC
